Emergence of a Streptococcus pneumoniae isolate resistant to streptogramins by mutation in ribosomal protein L22 during pristinamycin therapy of pneumococcal pneumonia

J Antimicrob Chemother. 2007 May;59(5):1010-2. doi: 10.1093/jac/dkm041. Epub 2007 Apr 13.

Abstract

Objectives: The aim of this study was to characterize the mechanism of resistance to macrolides and streptogramins of a Streptococcus pneumoniae strain isolated from blood cultures in an 80-year-old patient suffering from severe pneumonia unsuccessfully treated with pristinamycin.

Methods: Resistance genes erm(B) and mef(A) were searched for by PCR. Portions of genes for domains V and II of the 23S rRNA (rrl) and genes for ribosomal proteins L4 (rplD) and L22 (rplV) were amplified by PCR from total genomic DNA and sequenced.

Results: Resistance genes erm(B) and mef(A) were not detected. Only mutation in the rplV gene encoding ribosomal protein L22 was detected. The strain contained a six amino acid insertion ((107)KRTAHI(108)) in the C-terminus of the ribosomal protein L22.

Conclusions: This is the first report of emergence of a pneumococcus resistant to streptogramins by mutation in ribosomal protein L22 during treatment with pristinamycin.

MeSH terms

  • Aged, 80 and over
  • Amino Acid Sequence
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / genetics
  • Humans
  • Molecular Sequence Data
  • Pneumonia, Pneumococcal / drug therapy*
  • Pneumonia, Pneumococcal / microbiology
  • Pristinamycin / therapeutic use*
  • RNA, Ribosomal, 23S / genetics
  • Ribosomal Proteins / genetics*
  • Sequence Alignment
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / isolation & purification
  • Streptogramins / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • L22 protein, Streptococcus pneumoniae
  • Pristinamycin
  • RNA, Ribosomal, 23S
  • Ribosomal Proteins
  • Streptogramins